Insider Trading Alert - AA, JBHT And OHI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, July 21, 2014, 29 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $201.60 to $2,065,441.13.

Highlighted Stocks Traded by Insiders:

Alcoa (AA) - FREE Research Report

Morris Michael G, who is Director at Alcoa, bought 30,120 shares at $16.54 on July 21, 2014. Following this transaction, the Director owned 30,120 shares meaning that the stake was boosted by 100% with the 30,120-share transaction.

The shares most recently traded at $16.82, up $0.28, or 1.66% since the insider transaction. Historical insider transactions for Alcoa go as follows:

  • 4-Week # shares bought: 2,520
  • 4-Week # shares sold: 28,563
  • 12-Week # shares bought: 2,520
  • 12-Week # shares sold: 28,563
  • 24-Week # shares bought: 5,816
  • 24-Week # shares sold: 28,563

The average volume for Alcoa has been 14.9 million shares per day over the past 30 days. Alcoa has a market cap of $19.5 billion and is part of the basic materials sector and metals & mining industry. Shares are up 56.35% year-to-date as of the close of trading on Monday.

Alcoa Inc. produces and manages primary aluminum, fabricated aluminum, and alumina. The company operates in four segments: Alumina, Primary Metals, Global Rolled Products, and Engineered Products and Solutions. The stock currently has a dividend yield of 0.73%. Currently, there are 7 analysts who rate Alcoa a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AA - FREE

TheStreet Quant Ratings rates Alcoa as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, good cash flow from operations and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Alcoa Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

JB Hunt Transport Services (JBHT) - FREE Research Report

Harper Alfred C, who is EVP and Chief Operations Offic at JB Hunt Transport Services, sold 22,000 shares at $77.66 on July 21, 2014. Following this transaction, the EVP and Chief Operations Offic owned 37,724 shares meaning that the stake was reduced by 36.84% with the 22,000-share transaction.

The shares most recently traded at $78.69, up $1.03, or 1.3% since the insider transaction. Historical insider transactions for JB Hunt Transport Services go as follows:

  • 4-Week # shares sold: 965
  • 12-Week # shares sold: 97,675
  • 24-Week # shares sold: 109,175

The average volume for JB Hunt Transport Services has been 797,600 shares per day over the past 30 days. JB Hunt Transport Services has a market cap of $9.2 billion and is part of the services sector and transportation industry. Shares are up 1.01% year-to-date as of the close of trading on Monday.

J.B. Hunt Transport Services, Inc., together with its subsidiaries, provides transportation and delivery services in the continental United States, Canada, and Mexico. The stock currently has a dividend yield of 1.02%. The company has a P/E ratio of 27.1. Currently, there are 9 analysts who rate JB Hunt Transport Services a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JBHT - FREE

TheStreet Quant Ratings rates JB Hunt Transport Services as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, good cash flow from operations and increase in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full JB Hunt Transport Services Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Omega Healthcare Investors (OHI) - FREE Research Report

Booth Daniel J, who is Chief Operating Officer at Omega Healthcare Investors, sold 10,000 shares at $38.50 on July 21, 2014. Following this transaction, the Chief Operating Officer owned 168,895 shares meaning that the stake was reduced by 5.59% with the 10,000-share transaction.

The shares most recently traded at $38.17, down $0.33, or 0.86% since the insider transaction. Historical insider transactions for Omega Healthcare Investors go as follows:

  • 4-Week # shares bought: 32,424
  • 4-Week # shares sold: 72,500
  • 12-Week # shares bought: 32,424
  • 12-Week # shares sold: 130,000
  • 24-Week # shares bought: 32,424
  • 24-Week # shares sold: 152,500

The average volume for Omega Healthcare Investors has been 952,600 shares per day over the past 30 days. Omega Healthcare Investors has a market cap of $4.8 billion and is part of the financial sector and real estate industry. Shares are up 27.42% year-to-date as of the close of trading on Monday.

Omega Healthcare Investors, Inc. is a real estate investment firm. The firm invests in the real estate markets of United States. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio. Omega Healthcare Investors, Inc. The stock currently has a dividend yield of 5.29%. The company has a P/E ratio of 24.6. Currently, there is 1 analyst who rates Omega Healthcare Investors a buy, 2 analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OHI - FREE

TheStreet Quant Ratings rates Omega Healthcare Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in stock price during the past year, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Omega Healthcare Investors Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Global Stocks Weaken as Trump Opens New Fronts in Global Trade War

Global Stocks Weaken as Trump Opens New Fronts in Global Trade War

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat